Izbicka E - Search Results

1

Quantitative analysis of the effect of tubulin isotype expression on sensitivity of cancer cell lines to a set of novel colchicine derivatives.

Tseng CY, Mane JY, Winter P, Johnson L, Huzil T, Izbicka E, Luduena RF, Tuszynski JA. Tseng CY, et al. Among authors: izbicka e. Mol Cancer. 2010 May 30;9:131. doi: 10.1186/1476-4598-9-131. Mol Cancer. 2010. PMID: 20509970 Free PMC article.

2

Neuropeptide receptor status in human tumor cell lines.

Petit T, Davidson KK, Lawrence RA, von Hoff DD, Izbicka E. Petit T, et al. Among authors: izbicka e. Anticancer Drugs. 2001 Feb;12(2):133-6. doi: 10.1097/00001813-200102000-00006. Anticancer Drugs. 2001. PMID: 11261886

3

Effects of prolonged versus short-term exposure paclitaxel (Taxol) on human tumor colony-forming units.

Raymond E, Hanauske A, Faivre S, Izbicka E, Clark G, Rowinsky EK, Von Hoff DD. Raymond E, et al. Among authors: izbicka e. Anticancer Drugs. 1997 Apr;8(4):379-85. doi: 10.1097/00001813-199704000-00011. Anticancer Drugs. 1997. PMID: 9180392

4

Biomarkers for Sensitivity to Docetaxel and Paclitaxel in Human Tumor Cell Lines In Vitro.

Izbicka E, Campos D, Carrizales G, Tolcher A. Izbicka E, et al. Cancer Genomics Proteomics. 2005 Jul-Aug;2(4):219-226. Epub 2005 Jul 1. Cancer Genomics Proteomics. 2005. PMID: 31394710 Free article.

5

Significant activity of a novel cytotoxic agent, LY295501, against a wide range of tumors in the human tumor cloning system.

Diab SG, Hilsenbeck SG, Izbicka E, Weitman SD, Von Hoff DD. Diab SG, et al. Among authors: izbicka e. Anticancer Drugs. 1999 Mar;10(3):303-7. doi: 10.1097/00001813-199903000-00009. Anticancer Drugs. 1999. PMID: 10327037

6

Antitumor activity of irofulven against human ovarian cancer cell lines, human tumor colony-forming units, and xenografts.

van Laar ES, Izbicka E, Weitman S, Medina-Gundrum L, Macdonald JR, Waters SJ. van Laar ES, et al. Among authors: izbicka e. Int J Gynecol Cancer. 2004 Sep-Oct;14(5):824-31. doi: 10.1111/j.1048-891X.2004.014515.x. Int J Gynecol Cancer. 2004. PMID: 15361190

7

Exploring the mechanisms of action of FB642 at the cellular level.

Hammond LA, Davidson K, Lawrence R, Camden JB, Von Hoff DD, Weitman S, Izbicka E. Hammond LA, et al. Among authors: izbicka e. J Cancer Res Clin Oncol. 2001 May;127(5):301-13. doi: 10.1007/s004320000212. J Cancer Res Clin Oncol. 2001. PMID: 11355145

8

Effect of telomere and telomerase interactive agents on human tumor and normal cell lines.

Rha SY, Izbicka E, Lawrence R, Davidson K, Sun D, Moyer MP, Roodman GD, Hurley L, Von Hoff D. Rha SY, et al. Among authors: izbicka e. Clin Cancer Res. 2000 Mar;6(3):987-93. Clin Cancer Res. 2000. PMID: 10741725

9

Activity of MKT 077, a rhodacyanine dye, against human tumor colony-forming units.

Petit T, Izbicka E, Lawrence RA, Nalin C, Weitman SD, Von Hoff DD. Petit T, et al. Among authors: izbicka e. Anticancer Drugs. 1999 Mar;10(3):309-15. doi: 10.1097/00001813-199903000-00010. Anticancer Drugs. 1999. PMID: 10327038

10

Design and synthesis of fluoroquinophenoxazines that interact with human telomeric G-quadruplexes and their biological effects.

Duan W, Rangan A, Vankayalapati H, Kim MY, Zeng Q, Sun D, Han H, Fedoroff OY, Nishioka D, Rha SY, Izbicka E, Von Hoff DD, Hurley LH. Duan W, et al. Among authors: izbicka e. Mol Cancer Ther. 2001 Dec;1(2):103-20. Mol Cancer Ther. 2001. PMID: 12467228

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters